TY - JOUR
T1 - Effectiveness of a family-based health promotion intervention for women with prior GDM
T2 - The Face-it RCT
AU - Kragelund Nielsen, Karoline
AU - Dahl-Petersen, Inger Katrine
AU - Jensen, Dorte Møller
AU - Damm, Peter
AU - Ovesen, Per
AU - Mathiesen, Elisabeth R
AU - Kampmann, Ulla
AU - Vinter, Christina Anne
AU - Knorr, Sine
AU - Andersen, Lise Lotte
AU - Davidsen, Emma
AU - Jensen, Nanna Husted
AU - Aalders, Jori
AU - Thøgersen, Maja
AU - Timm, Anne
AU - Støvring, Henrik
AU - Maindal, Helle Terkildsen
N1 - © The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.
PY - 2024/12/9
Y1 - 2024/12/9
N2 - CONTEXT: Gestational diabetes mellitus (GDM) increases the risk of future type 2 diabetes (T2DM), but effective and feasible interventions to reduce this risk are lacking.OBJECTIVE: To evaluate the effectiveness of a family-based health promotion intervention on T2DM risk factors and quality of life among women with recent GDM.DESIGN: Multicenter, parallel, open-label randomized controlled trial with 2:1 allocation ratio.SETTING: Three sites in Denmark.PARTICIPANTS: Women diagnosed with GDM.INTERVENTION(S): The intervention consisted of (i) home visits with tailored family-based counseling (ii) digital health coaching, (iii) structured cross-sectoral communication.MAIN OUTCOME MEASURES: Primary outcomes were body mass index (BMI) and quality of life (SF12 MCS) 1-year after delivery.RESULTS: We randomized 277 women to the intervention (n=184) or usual care group (n=93). The intervention did not result in significantly lower BMI (-0.44 kg/m2; 95%CI -0.98 to 0.11) or higher SF12 MCS (0.06; 95%CI -2.15 to 2.27) compared to the usual care group. A pre-specified post hoc analysis demonstrated a reduced BMI in the intervention group among women with BMI ≥25 kg/m2 (-0.86 kg/m2; (-1.58 to -0.14)).Analyses of secondary and tertiary outcomes indicated significantly lower 2-h insulin (-94.3 pmmol/L; 95%CI -167.9 to -20.6) and triglycerides (-0.18 mmol/L; 95%CI -0.30 to -0.05) levels, and odds of fasting plasma glucose ≥6·1 mmol/L (OR 0.33; 95%CI 0.12 to 0.91) in the intervention group.CONCLUSION: The intervention did not result in lower BMI or increased quality of life, but seemingly reduced other risk factors, and lowered BMI in the subgroup of overweight women.
AB - CONTEXT: Gestational diabetes mellitus (GDM) increases the risk of future type 2 diabetes (T2DM), but effective and feasible interventions to reduce this risk are lacking.OBJECTIVE: To evaluate the effectiveness of a family-based health promotion intervention on T2DM risk factors and quality of life among women with recent GDM.DESIGN: Multicenter, parallel, open-label randomized controlled trial with 2:1 allocation ratio.SETTING: Three sites in Denmark.PARTICIPANTS: Women diagnosed with GDM.INTERVENTION(S): The intervention consisted of (i) home visits with tailored family-based counseling (ii) digital health coaching, (iii) structured cross-sectoral communication.MAIN OUTCOME MEASURES: Primary outcomes were body mass index (BMI) and quality of life (SF12 MCS) 1-year after delivery.RESULTS: We randomized 277 women to the intervention (n=184) or usual care group (n=93). The intervention did not result in significantly lower BMI (-0.44 kg/m2; 95%CI -0.98 to 0.11) or higher SF12 MCS (0.06; 95%CI -2.15 to 2.27) compared to the usual care group. A pre-specified post hoc analysis demonstrated a reduced BMI in the intervention group among women with BMI ≥25 kg/m2 (-0.86 kg/m2; (-1.58 to -0.14)).Analyses of secondary and tertiary outcomes indicated significantly lower 2-h insulin (-94.3 pmmol/L; 95%CI -167.9 to -20.6) and triglycerides (-0.18 mmol/L; 95%CI -0.30 to -0.05) levels, and odds of fasting plasma glucose ≥6·1 mmol/L (OR 0.33; 95%CI 0.12 to 0.91) in the intervention group.CONCLUSION: The intervention did not result in lower BMI or increased quality of life, but seemingly reduced other risk factors, and lowered BMI in the subgroup of overweight women.
U2 - 10.1210/clinem/dgae856
DO - 10.1210/clinem/dgae856
M3 - Journal article
C2 - 39657967
SN - 0021-972X
JO - The Journal of clinical endocrinology and metabolism
JF - The Journal of clinical endocrinology and metabolism
ER -